Meng Xin
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Ocular Surface and Contact Lens 10
- Co-authors
- Xianggen Wu (16 shared papers)Yanxin Sun (6 shared papers)Mengshuang Li (8 shared papers)Chongqi Jia (3 shared papers)Qiqi Li (4 shared papers)Chuanlong Guo (2 shared papers)Suyun Li (2 shared papers)Chongqi Jia (4 shared papers)
- Journals
- International Journal of Pharmaceutics (2 papers)Journal of Pharmaceutical Sciences (2 papers)Experimental Eye Research (2 papers)BMC Cardiovascular Disorders (2 papers)Drug Delivery and Translational Research (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Meng Xin
68 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 123
- Pharmaceutical Science 137
- Molecular Medicine 57
- Pharmacology 58
- Ophthalmology 54
- Cancer Research 79
Countries citing papers authored by Meng Xin
This map shows the geographic impact of Meng Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Xin more than expected).
Fields of papers citing papers by Meng Xin
This network shows the impact of papers produced by Meng Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Xin. The network helps show where Meng Xin may publish in the future.
Co-authors
The 25 scholars most cited alongside Meng Xin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 92 | |
| 2 | 2010 | 53 | |
| 3 | 2017 | 53 | |
| 4 | 2019 | 47 | |
| 5 | 2019 | 43 | |
| 6 | 2021 | 43 | |
| 7 | 2017 | 36 | |
| 8 | 2018 | 36 | |
| 9 | 2018 | 32 | |
| 10 | 2021 | 32 | |
| 11 | 2017 | 31 | |
| 12 | 2020 | 29 | |
| 13 | 2021 | 26 | |
| 14 | 2021 | 25 | |
| 15 | 2015 | 23 | |
| 16 | 2023 | 23 | |
| 17 | 2016 | 22 | |
| 18 | 2018 | 20 | |
| 19 | 2016 | 20 | |
| 20 | 2024 | 19 |
About Meng Xin
Meng Xin is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Biomedical Engineering, Cardiology and Cardiovascular Medicine and Pharmaceutical Science, having authored 71 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ocular Surface and Contact Lens (10 papers), Mechanical Circulatory Support Devices (5 papers), Advanced Drug Delivery Systems (5 papers), Advanced Glycation End Products research (4 papers), Ocular Infections and Treatments (3 papers), Pharmacological Effects of Natural Compounds (3 papers), MicroRNA in disease regulation (3 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Pharmaceutical Science (137 citations), Molecular Medicine (57 citations), Pharmacology (58 citations), Ophthalmology (54 citations) and Cancer Research (79 citations). Meng Xin has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xianggen Wu, Yanxin Sun, Mengshuang Li, Chongqi Jia, Qiqi Li, Chuanlong Guo, Suyun Li, Chongqi Jia, Lina Yang and Yuzhen Hou. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences, Experimental Eye Research, BMC Cardiovascular Disorders and Drug Delivery and Translational Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.